Analysed CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) News Sources
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
07-05-2026
yahoo.com
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
19-05-2026
yahoo.com
Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event
03-06-2026
yahoo.com
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
24-06-2026
yahoo.com
Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
01-07-2026
yahoo.com
Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress
13-07-2026
yahoo.com
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
21-07-2026
yahoo.com
CVKD: Positive CAD-1005 Data Accelerates Transition Toward Business Development Strategy
03-08-2026
yahoo.com
What is the current price of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The current price of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is $1.57.
CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) absolute price change since previous trading day?
The absolute price change of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) since the previous trading day is $-0.04.
CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) percentage price change since previous trading day?
The percentage price change of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) since the previous trading day is -2.4845%.
What is the most recent average sentiment score for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The most recent average sentiment score for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The most recent sentiment for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is .
SEC-8K** Filing Available For CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.